I have seen it from annual (one year) up to 3 years ... well and companies not doing any type of review haha. I think two years may be enough, but most management systems are shifting to a risk-based approach including if you are certified or following ISO 13485:2016. This is another opportunity to use a risk-based approach on review period because some procedures may change often, i.e. complaint handling or risk management, while some procedures don't change very much, i.e. management review. You should have a procedure review period, but take an opportunity to use a risk-based approach to identify those procedures in the QMS that have a greater impact that may need to be reviewed more often like annually, versus other procedures that have low impact or do not require that much change, to have a review period of 2 or 3 years.
------------------------------
Richard Vincins RAC
Vice President Regulatory Affairs
------------------------------
Original Message:
Sent: 07-Apr-2018 08:48
From: Jeanne Roscoe
Subject: SOP review timelines
Multiple IVD medical device instrument companies I have worked at have had a 2 year review of SOPs.
Does anyone know if this goes back to a guidance?